Tenderwize
Retour à la recherche

Accord de remise non exclusif pour l'Ustekinumab

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline May 27, 2028 · 553 days left·Open·Supplies·Framework
Titre original de l'avis

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Ustekinumab (ATC-Code: L04AC05).

56/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

56 / 100

Complexité

64 / 100

Facteurs de risque

The provided notice does not state the discount level, expected quantities, reimbursement exposure, or any guaranteed p...

Open-house contracts may end automatically when exclusive contracts enter into force, potentially shortening the expect...

No procurement documents available

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Niedersachsen. Die Gesundheitskasse.
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
May 27, 2028

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jul 2028
  • Conclusion of a non-exclusive discount agreement under § 130a(8) SGB V for medicines containing Ustekinumab, ATC code L04AC05.
  • Agreement coverage is associated with Germany, including the specified performance region DE929.
Afficher le résumé complet

AOK Niedersachsen is offering a non-exclusive open-house discount agreement for medicines containing Ustekinumab (ATC L04AC05) in Germany. Eligible pharmaceutical companies may join on uniform, non-negotiable terms without a selection decision. The agreement may run for up to 24 months from 1 August 2026 to 31 July 2028, but may be terminated earlier if exclusive contracts enter into force. No contract value is provided, and the procurement documents and contractual conditions were not included for review.

Risques

The provided notice does not state the discount level, expected quantities, reimbursement exposure, or any guaranteed p...

Open-house contracts may end automatically when exclusive contracts enter into force, potentially shortening the expect...

No procurement documents available

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Participation is limited to pharmaceutical entrepreneurs within the meaning of § 4(18) AMG, or a consortium of pharmaceutical entrepreneurs, in relation to the offered medicines.
  • The pharmaceutical entrepreneur must be permitted to place medicines on the market within the scope of the AMG.
  • A pharmaceutical entrepreneur must have its registered seat in Germany, another EU Member State, or another EEA contracting state, as stated in the notice.

Acheteur

Localisation

Hannover, DEU

Identifiant

AOK- Niedersachsen. Die Gesundheitskasse

Activité

Health

Lots (1)

LOT-0000

Ustekinumab Non-Exclusive Discount Agreement

Open-house discount agreement for medicines containing Ustekinumab (ATC L04AC05). Participation is available to all interested eligible pharmaceutical companies under identical conditions, without individual negotiations or an award selection. Contracts may be concluded during the term, subject to the applicable advance notice and submission deadlines.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE929, Germany

Durée

Jul 2026 - Jul 2028

Catégorie

Pharmaceutical products

Date limite

Deadline May 27, 2028

Détails de la procédure

Date de publication
14 Jun 2026
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
407882-2026

Appels d'offres similaires

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy